Quest diagnostics reports first quarter 2025 financial results; reaffirms revenue and adjusted diluted eps guidance for full year 2025

First quarter revenues of $2.65 billion, up 12.1% from 2024 first quarter reported diluted earnings per share ("eps") of $1.94, up 12.8% from 2024; and adjusted diluted eps of $2.21, up 8.3% from 2024 full year 2025 reported diluted eps now expected to be between $8.62 and $8.87; and adjusted diluted eps is expected to remain between $9.55 and $9.80 secaucus, n.j. , april 22, 2025 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), a leading provider of diagnostic information services, today announced financial results for the first quarter ended march 31, 2025.
DGX Ratings Summary
DGX Quant Ranking